STOCK TITAN

CELC insider proposes 100K-share sale worth $4.4M under Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Celcuity Inc. (CELC) filed a Form 144 indicating an intention to sell up to 100,000 common shares through RBC Capital Markets on or about 28 Jul 2025. At the filing’s reference price, the shares have an aggregate market value of $4.398 million and represent roughly 0.3 % of the 37.87 million shares outstanding.

The shares were originally acquired on 28 Feb 2014 via an investment transaction paid by check. The filer reports no sales of Celcuity securities in the past three months. The notice states that the seller is unaware of any undisclosed material adverse information and affirms compliance with Rule 10b5-1 if applicable. The planned sale will take place on the NASDAQ exchange. No additional financial data, earnings information, or prior insider transactions are disclosed in this filing.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: 100 K-share Form 144 signals modest insider liquidity; minimal dilution and limited market impact.

The proposed sale equals about 0.26 % of Celcuity’s float, a size unlikely to pressure the stock materially under normal trading volumes. Because Form 144 is only a notice and not a mandatory sale, execution may vary. The lack of recent selling history and the long holding period (since 2014) suggest a routine diversification move rather than a negative view on fundamentals. Still, investors often monitor insider sales for sentiment cues, so short-term optics could be mildly negative. Overall, the filing is neutral from a valuation perspective and does not alter the investment thesis.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many CELC shares are registered for sale in this Form 144?

The filing covers 100,000 common shares of Celcuity Inc.

What is the aggregate market value of the proposed CELC share sale?

The 100,000 shares are valued at approximately $4.398 million based on the filing’s reference price.

When is the anticipated sale date for the Celcuity shares?

The filer lists an approximate sale date of 28 Jul 2025.

How does the share amount compare to Celcuity’s shares outstanding?

The sale equals roughly 0.3 % of the 37.87 million CELC shares outstanding.

Were any CELC shares sold by this filer in the past three months?

No; the Form 144 states "Nothing to Report" for sales in the prior three-month period.
Celcuity Inc

NASDAQ:CELC

CELC Rankings

CELC Latest News

CELC Latest SEC Filings

CELC Stock Data

4.94B
38.03M
Biotechnology
Services-medical Laboratories
Link
United States
MINNEAPOLIS